A rare cutaneous manifestation of immune checkpoint inhibitor therapy

Leukocytoclastic vasculitis can be an uncommon and/or underreported adverse event of immune checkpoint inhibitor therapy, an established cancer treatment option. Differentiation among other cutaneous manifestations of adverse medication reactions—such as Stevens–Johnson syndrome, erythema multiforme...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherneskie, John, Tuan, Alyssa, Corey, Zachary, Polimera, Hyma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067804/
https://www.ncbi.nlm.nih.gov/pubmed/37020667
http://dx.doi.org/10.1002/ccr3.7151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067804/
https://www.ncbi.nlm.nih.gov/pubmed/37020667
http://dx.doi.org/10.1002/ccr3.7151

Ejemplares similares